Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0000917520-24-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-08 | 2024-03-06 | IART | DAVIS ROBERT T. JR. | EVP, Pres, TT | M - OptEx | $32.59 | +8,736 | 58.2K | +18% | +$284.7K |
| D | 2024-03-08 | 2024-03-06 | IART | DAVIS ROBERT T. JR. | EVP, Pres, TT | S - Sale+OE | $36.59 | -8,348 | 49.9K | -14% | -$305.5K |
| D | 2024-03-08 | 2024-03-06 | IART | DAVIS ROBERT T. JR. | EVP, Pres, TT | M - OptEx | $0.00 | -8,736 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-06 | M | A | 8,736 | $32.59 | 58,241 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-06 | S | D | 8,348 | $36.59 | 49,893 | D | — | — | (F1) Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire. (F2) The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-06 | M | D | 8,736 | $0.00 | 0 | D | $32.59 · — to 2024-03-14 | 8,736 Common Stock | (F3) 25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016. |